Dow Up 1.31% Nasdaq Up 2.40%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.32 0.06(4.35%) Oct 21, 4:00PM EDT
Prev Close:1.38
Open:1.40
Bid:0.97 x 100
Ask:1.44 x 900
1y Target Est:3.10
Beta:1.27
Next Earnings Date:N/A
Day's Range:1.29 - 1.40
52wk Range:1.07 - 5.19
Volume:1,291,121
Avg Vol (3m):1,773,850
Market Cap:186.18M
P/E (ttm):N/A
EPS (ttm):-0.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXDown 4.35%186.18M
AZN87.15B
GSK104.80B
PFE179.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback